user: GUEST
width: 600



DescriptionRecName: Full=Zinc finger and BTB domain-containing protein 4; AltName: Full=KAISO-like zinc finger protein 1; Short=KAISO-L1;
MyHits logo
MyHits synonymsZBTB4_HUMAN , Q9P1Z0 , B3KVL6 , Q7Z697 , Q86XJ4 , Q8N4V8 , CA4AB6A5230C2F52
match map segment
iprf:ZINC_FINGER_C2H2_2 ipat:ZINC_FINGER_C2H2_1 iprf:ZINC_FINGER_C2H2_2 iprf:ZINC_FINGER_C2H2_2 iprf:ZINC_FINGER_C2H2_2 iprf:ZINC_FINGER_C2H2_2 ismart:ZnF_C2H2 ismart:ZnF_C2H2 ismart:BTB ipat:ZINC_FINGER_C2H2_1 ipfam:BTB ipat:ZINC_FINGER_C2H2_1 ismart:ZnF_C2H2 ipat:ZINC_FINGER_C2H2_1 iprf:ZINC_FINGER_C2H2_2 ipat:ZINC_FINGER_C2H2_1 ismart:ZnF_C2H2 iprf:BTB ismart:ZnF_C2H2 ismart:ZnF_C2H2  
Legends: 1, Phosphoserine. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}; 2, Phosphothreonine; by HIPK2. {ECO:0000269|PubMed:19448668}; 3, CROSSLNK Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:25755297}; 4, CROSSLNK Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2). {ECO:0000244|PubMed:25218447}; 5, VARIANT A -> V (in dbSNP:rs35231078); 6, VARIANT M -> I (in dbSNP:rs871990); 7, VARIANT N -> S (in dbSNP:rs34914463); 8, MUTAGEN T->A: Impaired HIPK2-mediated phosphorylation; when associated with A- 797 and A-983. {ECO:0000269|PubMed:19448668}; 9, MUTAGEN T->A: Impaired HIPK2-mediated phosphorylation; when associated with A- 795 and A-983. {ECO:0000269|PubMed:19448668}; 10, MUTAGEN T->A: Impaired HIPK2-mediated phosphorylation; when associated with A- 795 and A-797. {ECO:0000269|PubMed:19448668}; 11, CONFLICT P -> S (in Ref. 6; AAH43352). {ECO:0000305}; 12, CONFLICT R -> C (in Ref. 6; AAH43352). {ECO:0000305}; 13, BTB. {ECO:0000255|PROSITE- ProRule:PRU00037}; 14, ZN_FING C2H2-type 1; atypical. {ECO:0000255|PROSITE-ProRule:PRU00042}; 15, ZN_FING C2H2-type 2. {ECO:0000255|PROSITE- ProRule:PRU00042}; 16, ZN_FING C2H2-type 3. {ECO:0000255|PROSITE- ProRule:PRU00042}; 17, ZN_FING C2H2-type 4. {ECO:0000255|PROSITE- ProRule:PRU00042}; 18, ZN_FING C2H2-type 5. {ECO:0000255|PROSITE- ProRule:PRU00042}; 19, ZN_FING C2H2-type 6. {ECO:0000255|PROSITE- ProRule:PRU00042}; 20, REGION Interaction with CBFA2T3. {ECO:0000269|PubMed:23251453}; 21, COILED {ECO:0000255}; 22, COMPBIAS Pro-rich; 23, COMPBIAS Glu-rich; 24, iprf:ZINC_FINGER_C2H2_2 [T]; 25, ipat:ZINC_FINGER_C2H2_1 [T]; 26, ismart:ZnF_C2H2 [T]; 27, ipfam:BTB [T].
ID   ZBTB4_HUMAN             Reviewed;        1013 AA.
AC   Q9P1Z0; B3KVL6; Q7Z697; Q86XJ4; Q8N4V8;
DT   26-APR-2004, integrated into UniProtKB/Swiss-Prot.
DT   26-APR-2004, sequence version 3.
DT   10-MAY-2017, entry version 141.
DE   RecName: Full=Zinc finger and BTB domain-containing protein 4;
DE   AltName: Full=KAISO-like zinc finger protein 1;
DE            Short=KAISO-L1;
GN   Name=ZBTB4; Synonyms=KIAA1538;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Fetal brain;
RA   Weber A., Klinkhammer B., Glaum A., Bergmann E., Berwanger B.,
RA   Eilers M., Christiansen H.;
RT   "Identification of a novel zinc-finger-protein encoding gene on
RT   17p13.1.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=10819331; DOI=10.1093/dnares/7.2.143;
RA   Nagase T., Kikuno R., Ishikawa K., Hirosawa M., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XVII.
RT   The complete sequences of 100 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 7:143-150(2000).
RN   [3]
RP   SEQUENCE REVISION.
RX   PubMed=12168954; DOI=10.1093/dnares/9.3.99;
RA   Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T.;
RT   "Construction of expression-ready cDNA clones for KIAA genes: manual
RT   curation of 330 KIAA cDNA clones.";
RL   DNA Res. 9:99-106(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Uterus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   FUNCTION, DNA-BINDING, SUBCELLULAR LOCATION, AND INTERACTION WITH
RP   ZBTB38.
RX   PubMed=16354688; DOI=10.1128/MCB.26.1.169-181.2006;
RA   Filion G.J., Zhenilo S., Salozhin S., Yamada D., Prokhortchouk E.,
RA   Defossez P.A.;
RT   "A family of human zinc finger proteins that bind methylated DNA and
RT   repress transcription.";
RL   Mol. Cell. Biol. 26:169-181(2006).
RN   [8]
RP   PHOSPHORYLATION AT THR-795; THR-797 AND THR-983 BY HIPK2, MUTAGENESIS
RP   OF THR-795; THR-797 AND THR-983, AND INTERACTION WITH HIPK2.
RX   PubMed=19448668; DOI=10.1038/onc.2009.109;
RA   Yamada D., Perez-Torrado R., Filion G., Caly M., Jammart B.,
RA   Devignot V., Sasai N., Ravassard P., Mallet J., Sastre-Garau X.,
RA   Schmitz M.L., Defossez P.A.;
RT   "The human protein kinase HIPK2 phosphorylates and downregulates the
RT   methyl-binding transcription factor ZBTB4.";
RL   Oncogene 28:2535-2544(2009).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-391, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [10]
RP   INTERACTION WITH CBFA2T3.
RX   PubMed=23251453; DOI=10.1371/journal.pone.0051205;
RA   Barrett C.W., Smith J.J., Lu L.C., Markham N., Stengel K.R.,
RA   Short S.P., Zhang B., Hunt A.A., Fingleton B.M., Carnahan R.H.,
RA   Engel M.E., Chen X., Beauchamp R.D., Wilson K.T., Hiebert S.W.,
RA   Reynolds A.B., Williams C.S.;
RT   "Kaiso directs the transcriptional corepressor MTG16 to the Kaiso
RT   binding site in target promoters.";
RL   PLoS ONE 7:E51205-E51205(2012).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-391, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [12]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-615, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [13]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-40, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25755297; DOI=10.1074/mcp.O114.044792;
RA   Xiao Z., Chang J.G., Hendriks I.A., Sigurdsson J.O., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "System-wide analysis of SUMOylation dynamics in response to
RT   replication stress reveals novel small ubiquitin-like modified target
RT   proteins and acceptor lysines relevant for genome stability.";
RL   Mol. Cell. Proteomics 14:1419-1434(2015).
CC   -!- FUNCTION: Transcriptional repressor with bimodal DNA-binding
CC       specificity. Represses transcription in a methyl-CpG-dependent
CC       manner. Binds with a higher affinity to methylated CpG
CC       dinucleotides in the consensus sequence 5'-CGCG-3' but can also
CC       bind to the non-methylated consensus sequence 5'-CTGCNA-3' also
CC       known as the consensus kaiso binding site (KBS). Can also bind
CC       specifically to a single methyl-CpG pair and can bind
CC       hemimethylated DNA but with a lower affinity compared to
CC       methylated DNA (PubMed:16354688). {ECO:0000269|PubMed:16354688}.
CC   -!- SUBUNIT: Interacts with HIPK2. Interacts with CBFA2T3. Interacts
CC       with ZBTB38. {ECO:0000269|PubMed:16354688,
CC       ECO:0000269|PubMed:19448668, ECO:0000269|PubMed:23251453}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:16354688}.
CC       Chromosome {ECO:0000269|PubMed:16354688}. Note=Localizes to
CC       chromocenters. {ECO:0000269|PubMed:16354688}.
CC   -!- PTM: Phosphorylated by HIPK2. This phosphorylation reduces
CC       stability and triggers ZBTB4 protein degradation in response to
CC       DNA damage. {ECO:0000269|PubMed:19448668}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA96062.2; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY302699; AAP59447.1; -; mRNA.
DR   EMBL; AB040971; BAA96062.2; ALT_INIT; mRNA.
DR   EMBL; AK122971; BAG53828.1; -; mRNA.
DR   EMBL; CH471108; EAW90185.1; -; Genomic_DNA.
DR   EMBL; BC033259; AAH33259.1; -; mRNA.
DR   EMBL; BC043352; AAH43352.1; -; mRNA.
DR   CCDS; CCDS11107.1; -.
DR   RefSeq; NP_001122305.1; NM_001128833.1.
DR   RefSeq; NP_065950.2; NM_020899.3.
DR   RefSeq; XP_006721626.1; XM_006721563.3.
DR   RefSeq; XP_006721627.1; XM_006721564.2.
DR   RefSeq; XP_011522274.1; XM_011523972.2.
DR   UniGene; Hs.35096; -.
DR   ProteinModelPortal; Q9P1Z0; -.
DR   SMR; Q9P1Z0; -.
DR   BioGrid; 121693; 7.
DR   IntAct; Q9P1Z0; 15.
DR   STRING; 9606.ENSP00000307858; -.
DR   iPTMnet; Q9P1Z0; -.
DR   PhosphoSitePlus; Q9P1Z0; -.
DR   BioMuta; ZBTB4; -.
DR   DMDM; 46577564; -.
DR   EPD; Q9P1Z0; -.
DR   MaxQB; Q9P1Z0; -.
DR   PaxDb; Q9P1Z0; -.
DR   PeptideAtlas; Q9P1Z0; -.
DR   PRIDE; Q9P1Z0; -.
DR   Ensembl; ENST00000311403; ENSP00000307858; ENSG00000174282.
DR   Ensembl; ENST00000380599; ENSP00000369973; ENSG00000174282.
DR   GeneID; 57659; -.
DR   KEGG; hsa:57659; -.
DR   UCSC; uc002ghc.5; human.
DR   CTD; 57659; -.
DR   DisGeNET; 57659; -.
DR   GeneCards; ZBTB4; -.
DR   HGNC; HGNC:23847; ZBTB4.
DR   HPA; CAB008980; -.
DR   HPA; HPA064763; -.
DR   MIM; 612308; gene.
DR   neXtProt; NX_Q9P1Z0; -.
DR   OpenTargets; ENSG00000174282; -.
DR   PharmGKB; PA134959224; -.
DR   eggNOG; KOG1721; Eukaryota.
DR   eggNOG; COG5048; LUCA.
DR   GeneTree; ENSGT00810000125416; -.
DR   HOGENOM; HOG000065759; -.
DR   HOVERGEN; HBG055508; -.
DR   InParanoid; Q9P1Z0; -.
DR   KO; K10491; -.
DR   OMA; NMVLPDE; -.
DR   OrthoDB; EOG091G01R6; -.
DR   PhylomeDB; Q9P1Z0; -.
DR   TreeFam; TF333100; -.
DR   ChiTaRS; ZBTB4; human.
DR   GenomeRNAi; 57659; -.
DR   PRO; PR:Q9P1Z0; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000174282; -.
DR   CleanEx; HS_ZBTB4; -.
DR   Genevisible; Q9P1Z0; HS.
DR   GO; GO:0005694; C:chromosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0016604; C:nuclear body; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0008327; F:methyl-CpG binding; IDA:UniProtKB.
DR   GO; GO:0010428; F:methyl-CpNpG binding; IDA:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB.
DR   GO; GO:0019901; F:protein kinase binding; IPI:UniProtKB.
DR   GO; GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IDA:UniProtKB.
DR   GO; GO:0001227; F:transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding; IDA:NTNU_SB.
DR   GO; GO:0006974; P:cellular response to DNA damage stimulus; IDA:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:NTNU_SB.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   InterPro; IPR000210; BTB/POZ_dom.
DR   InterPro; IPR011333; SKP1/BTB/POZ.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   Pfam; PF00651; BTB; 1.
DR   SMART; SM00225; BTB; 1.
DR   SMART; SM00355; ZnF_C2H2; 6.
DR   SUPFAM; SSF54695; SSF54695; 2.
DR   SUPFAM; SSF57667; SSF57667; 3.
DR   PROSITE; PS50097; BTB; 1.
DR   PROSITE; PS00028; ZINC_FINGER_C2H2_1; 5.
DR   PROSITE; PS50157; ZINC_FINGER_C2H2_2; 6.
PE   1: Evidence at protein level;
KW   Chromosome; Coiled coil; Complete proteome; DNA-binding;
KW   Isopeptide bond; Metal-binding; Nucleus; Phosphoprotein; Polymorphism;
KW   Reference proteome; Repeat; Repressor; Transcription;
KW   Transcription regulation; Ubl conjugation; Zinc; Zinc-finger.
FT   CHAIN         1   1013       Zinc finger and BTB domain-containing
FT                                protein 4.
FT                                /FTId=PRO_0000047712.
FT   DOMAIN       30    152       BTB. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00037}.
FT   ZN_FING     234    256       C2H2-type 1; atypical.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00042}.
FT   ZN_FING     309    331       C2H2-type 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     337    359       C2H2-type 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     365    388       C2H2-type 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     726    748       C2H2-type 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     765    787       C2H2-type 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   REGION      186    348       Interaction with CBFA2T3.
FT                                {ECO:0000269|PubMed:23251453}.
FT   COILED      627    663       {ECO:0000255}.
FT   COMPBIAS    435    536       Pro-rich.
FT   COMPBIAS    610    654       Glu-rich.
FT   MOD_RES     391    391       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     795    795       Phosphothreonine; by HIPK2.
FT                                {ECO:0000269|PubMed:19448668}.
FT   MOD_RES     797    797       Phosphothreonine; by HIPK2.
FT                                {ECO:0000269|PubMed:19448668}.
FT   MOD_RES     983    983       Phosphothreonine; by HIPK2.
FT                                {ECO:0000269|PubMed:19448668}.
FT   CROSSLNK     40     40       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25755297}.
FT   CROSSLNK    615    615       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25218447}.
FT   VARIANT     539    539       A -> V (in dbSNP:rs35231078).
FT                                /FTId=VAR_052913.
FT   VARIANT     550    550       M -> I (in dbSNP:rs871990).
FT                                /FTId=VAR_018383.
FT   VARIANT     561    561       N -> S (in dbSNP:rs34914463).
FT                                /FTId=VAR_052914.
FT   MUTAGEN     795    795       T->A: Impaired HIPK2-mediated
FT                                phosphorylation; when associated with A-
FT                                797 and A-983.
FT                                {ECO:0000269|PubMed:19448668}.
FT   MUTAGEN     797    797       T->A: Impaired HIPK2-mediated
FT                                phosphorylation; when associated with A-
FT                                795 and A-983.
FT                                {ECO:0000269|PubMed:19448668}.
FT   MUTAGEN     983    983       T->A: Impaired HIPK2-mediated
FT                                phosphorylation; when associated with A-
FT                                795 and A-797.
FT                                {ECO:0000269|PubMed:19448668}.
FT   CONFLICT    188    188       P -> S (in Ref. 6; AAH43352).
FT                                {ECO:0000305}.
FT   CONFLICT    674    674       R -> C (in Ref. 6; AAH43352).
FT                                {ECO:0000305}.
CC   --------------------------------------------------------------------------
CC   The following FT lines are automated annotations from the MyHits database.
CC   --------------------------------------------------------------------------
FT   MYHIT       765    792       iprf:ZINC_FINGER_C2H2_2 [T]
FT   MYHIT       339    359       ipat:ZINC_FINGER_C2H2_1 [T]
FT   MYHIT       337    364       iprf:ZINC_FINGER_C2H2_2 [T]
FT   MYHIT       365    388       iprf:ZINC_FINGER_C2H2_2 [T]
FT   MYHIT       234    262       iprf:ZINC_FINGER_C2H2_2 [T]
FT   MYHIT       726    753       iprf:ZINC_FINGER_C2H2_2 [T]
FT   MYHIT       337    359       ismart:ZnF_C2H2 [T]
FT   MYHIT       726    748       ismart:ZnF_C2H2 [T]
FT   MYHIT        30    187       ismart:BTB [T]
FT   MYHIT       311    331       ipat:ZINC_FINGER_C2H2_1 [T]
FT   MYHIT        20     60       ipfam:BTB [T]
FT   MYHIT       367    388       ipat:ZINC_FINGER_C2H2_1 [T]
FT   MYHIT       765    787       ismart:ZnF_C2H2 [T]
FT   MYHIT       728    748       ipat:ZINC_FINGER_C2H2_1 [T]
FT   MYHIT       309    336       iprf:ZINC_FINGER_C2H2_2 [T]
FT   MYHIT       767    787       ipat:ZINC_FINGER_C2H2_1 [T]
FT   MYHIT       365    388       ismart:ZnF_C2H2 [T]
FT   MYHIT        30    152       iprf:BTB [T]
FT   MYHIT       234    254       ismart:ZnF_C2H2 [T]
FT   MYHIT       309    331       ismart:ZnF_C2H2 [T]
SQ   SEQUENCE   1013 AA;  105114 MW;  CA4AB6A5230C2F52 CRC64;
     MPPPAEVTDP SHAPAVLRQL NEQRLRGLFC DVTLIAGDTK FPAHRSVLAA SSPFFREALL
     TSAPLPLPPA TGGAAPNPAT TTAASSSSSS SSSSSSSSSS ASSSSSSSSS SPPPASPPAS
     SPPRVLELPG VPAAAFSDVL NFIYSARLAL PGGGGDGAAV AEIGALGRRL GISRLQGLGE
     GGDAWVPPTP APMATSQPEE DSFGPGPRPA GEWEGDRAEA QAPDLQCSLP RRPLPCPQCG
     KSFIHPKRLQ THEAQCRRGA STRGSTGLGA GGAGPGGPAG VDASALPPPV GFRGGPEHVV
     KVVGGHVLYV CAACERSYVT LSSLKRHSNV HSWRRKYPCR YCEKVFALAE YRTKHEVWHT
     GERRYQCIFC WETFVTYYNL KTHQRAFHGI SPGLLASEKT PNGGYKPKLN TLKLYRLLPM
     RAAKRPYKTY SQGAPEAPLS PTLNTPAPVA MPASPPPGPP PAPEPGPPPS VITFAHPAPS
     VIVHGGSSSG GGGSGTASTG GSQAASVITY TAPPRPPKKR EYPPPPPEPA ATPTSPATAV
     SPATAAGPAM ATTTEEAKGR NPRAGRTLTY TAKPVGGIGG GGGPPTGAGR GPSQLQAPPP
     LCQITVRIGE EAIVKRRISE TDLRPGELSG EEMEESEEDE EEEDEEEEEE DEEESKAGGE
     DQLWRPYYSY KPKRKAGAAG GASVGGSGLP RGRRPPRWRQ KLERRSWEET PAAESPAGRA
     RTERRHRCGD CAQTFTTLRK LRKHQEAHGG GSHSSRAGRR PSTRFTCPHC AKVCKTAAAL
     SRHGQRHAAE RPGGTPTPVI AYSKGSAGTR PGDVKEEAPQ EMQVSSSSGE AGGGSTAAEE
     ASETASLQDP IISGGEEPPV VASGGSYVYP PVQEFPLALI GGGREPGGGR GKSGSEGPVG
     AGEGDRMEGI GAAKVTFYPE PYPLVYGPQL LAAYPYNFSN LAALPVALNM VLPDEKGAGA
     LPFLPGVFGY AVNPQAAPPA PPTPPPPTLP PPIPPKGEGE RAGVERTQKG DVG
//